EMA addresses criticism of management procedures
This article was originally published in Scrip
The European Medicines Agency is preparing a detailed report in response to concerns raised in the European Parliament regarding the independence of agency experts carrying out scientific evaluations of human medicines, the management of its procurement procedures and the criteria for recruiting staff.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.